Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery. The article describes the management of the condition, the nursing care and the screening available for susceptible patients.
Nursing Standard. 20, 28, 51-57. doi: 10.7748/ns2006.03.20.28.51.c4101
Correspondence Peer reviewThis article has been subject to double blind peer review
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
